IGISU Co., Ltd.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
5
Ending by 2030
Jul 2030
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
No maintenance fee falls due on this company's record before Nov 21, 2027.
Recent changes
- 1 term has ended since Aug 23, 2026
- Sep 27 US 11,452,762 Method of Treating Rhinitis with C-Type Natriuretic Peptides · lapsed on the fee record
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 10 of 10
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,358,269 | Method for treating dermatitis and improving skin texture using natriuretic peptides In force · USPTO record | In force | USPTO record | |
| US 9,968,654 | Method of treatment dermatitis with c-type natriuretic peptide derivatives In force · USPTO record | In force | USPTO record | |
| US 10,946,072 | Method for treating dermatitis and improving skin texture using B-type natriuretic peptides In force · USPTO record | In force | USPTO record | |
| US 9,358,270 | Method of Treating Rhinitis with B-Type and C-Type Natriuretic Peptides In force · High confidence | In force | High confidence | |
| US 9,962,429 | Method for Treating Rhinitis with B and C-Type Natriuretic Peptide Containing Chimeric Ring Structures In force · High confidence | In force | High confidence | |
| US 9,480,728 | Agent for the treatment of alopecia In force · USPTO record | In force | USPTO record | |
| US 9,808,511 | Method for treating alopecia with B-type natriuretic peptide In force · USPTO record | In force | USPTO record | |
| US 11,571,464 | C-Type Natriuretic Peptide Agent for the Treatment of Alopecia In force · Low confidence | In force | Low confidence | |
| US 12,221,495 | Cyclic peptide and a medicament, external preparation and cosmetic comprising said cyclic peptide In force · USPTO record | In force | USPTO record | |
| US 12,065,512 | Cyclic peptide and a medicament, external preparation and cosmetic comprising said cyclic peptide In force · USPTO record | In force | USPTO record |
Also on record, not counted in the 10: 1 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending · 1 abandoned · 2 no status recorded
Showing 1 to 5 of 5, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.
| Application | Title | Filed | Status |
|---|---|---|---|
| 18/626,956 | CNP Cyclic Peptide, and Medicine, External Preparation and Cosmetic Each Containing Said Cyclic Peptide | Apr 4, 2024 | Pending |
| 15/749,275 | CNP Cyclic Peptide, and Medicine, External Preparation and Cosmetic Each Containing Said Cyclic Peptide | Aug 1, 2016 | Pending |
| 13/355,484 | Jan 21, 2012 | No status recorded | |
| 13/392,657 | Therapeutic Agent for Rhinitis | Aug 27, 2010 | Abandoned |
| 13/386,528 | Jul 23, 2010 | No status recorded |